查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
血管炎治療全球市場規模調查和預測：按藥物類別、疾病類型、分銷渠道和地區分析，2022-2029 年
市場調查報告書
商品編碼
1215482

血管炎治療全球市場規模調查和預測：按藥物類別、疾病類型、分銷渠道和地區分析，2022-2029 年

Global Vasculitis Treatment Market Size study & Forecast, by Drug Class, by Disease Type, by Distribution Channel and Regional Analysis, 2022-2029
出版日期: | 出版商: Bizwit Research & Consulting LLP | 英文 | 商品交期: 2-3個工作天內

價格

2021 年全球血管炎治療市場價值約為 2.501 億美元，預計在 2022-2029 年預測期內將以超過 3.4% 的健康增長率增長。

血管炎治療是一種影響血管的罕見炎症性疾病。 這種炎症會使血管壁變厚，縮短通過它們的通道的寬度，並限制血液流動。 此外，血流受限會導致器官衰竭和組織損傷。 血管炎有多種類型，包括鉅細胞動脈炎（GCA）、大動脈炎（TAK）、主動脈炎、川崎病（KD）和結節性多動脈炎（PAN）。 血管炎的常見症狀和體徵包括發燒、頭痛、疲勞、體重減輕和全身酸痛。 血管炎患病率上升、慢性病患病率上升以及主要參與者的戰略舉措是加速市場增長的關鍵因素。

血管炎患病率的增加促進了全球血管炎治療市場的增長。 例如，根據 Vasculitis UK 的數據，截至 2020 年，血管炎每年影響 2000-3000 名英國居民。 此外，根據美國心臟協會雜誌——截至 2021 年 1 月，瑞典和挪威每年報告的 50 歲及以上人群中每 100,000 人中就有 20 多例 GCA 新病例。 此外，在美國，女性患 GCA 的終生風險估計為 1%，男性為 0.5%。 此外，活性藥物成分 (API) 行業的快速增長和新興市場醫療保健基礎設施的改善將為預測期內的市場提供良好的增長前景。 然而，與皮質類固醇相關的副作用和不利的報銷情況將阻礙整個 2022-2029 年預測期內的市場增長。

全球血管炎治療市場研究中考慮的主要區域是亞太地區、北美、歐洲、拉丁美洲和世界其他地區。 由於主要市場參與者的存在以及該地區血管炎發病率的增加，北美在收入方面佔據了市場主導地位。 另一方面，由於老年人口增加和製藥製造業擴張等因素，預計亞太地區在預測期內將以最高複合年增長率增長。

這項研究的目的是揭示近年來各個細分市場和國家/地區的市場規模，並預測未來幾年的市場規模。 該報告旨在捕捉被調查國家工業的定性和定量方面的情況。

它還提供了關鍵方面的詳細信息，例如決定市場未來增長的驅動因素和挑戰。 此外，它還包含供利益相關者投資的微觀市場潛在機會，以及對主要參與者的競爭格局和產品供應的深入分析。

按藥物類別

生物製品

皮質類固醇和免疫抑製劑

按疾病類型

中小血管炎

大血管炎

按銷售渠道

醫院藥房

藥店/零售商

在線藥店

內容

第 1 章執行摘要

  • 市場概況
  • 2019-2029 年各細分市場的全球市場估計和預測
    • 血管炎治療市場：按地區劃分，2019-2029
    • 血管炎治療市場：按藥物分類，2019-2029
    • 血管炎治療市場：按疾病類型分類，2019-2029
    • 血管炎治療市場：按分銷渠道，2019-2029 年
  • 主要趨勢
  • 調查方法
  • 調查先決條件

第 2 章血管炎治療全球市場定義和範圍

  • 調查的目的
  • 市場定義和範圍
    • 調查範圍
    • 工業發展
  • 調查年份
  • 貨幣兌換率

第 3 章血管炎治療的全球市場動態

  • 血管炎治療市場影響分析（2019-2029）
    • 市場驅動力
      • 血管炎患病率增加
      • 慢性病患病率增加
      • 主要市場參與者的戰略舉措
    • 市場挑戰
      • 與皮質類固醇有關的副作用
      • 不利的贖回情景
    • 市場機會
      • 不斷發展的活性藥物成分 (API) 行業
      • 發展中地區的醫療保健基礎設施有所增加

第 4 章全球血管炎治療市場行業分析

  • 波特 5 力模型
    • 供應商的議價能力
    • 買家的議價能力
    • 新進入者的威脅
    • 替代品的威脅
    • 競爭公司之間的敵對關係
  • 波特 5 力模型的未來方法 (2019-2029)
  • 害蟲分析
    • 政治
    • 經濟的
    • 社交
    • 技術
  • 頂級投資機會
  • 關鍵成功策略
  • 行業專家的展望
  • 分析師的結論和建議

第 5 章風險評估：COVID-19 的影響

  • 評估 COVID-19 對行業的總體影響
  • COVID-19 之前和 COVID-19 之後的市場情景

第 6 章全球血管炎治療市場，按藥物分類

  • 市場概況
  • 全球血管炎治療市場，按藥物類別，性能潛力分析
  • 2019-2029 年全球血管炎治療市場、按藥物類別估算和預測
  • 血管炎治療市場細分分析
    • 生物製劑
    • 皮質類固醇
    • 免疫抑製劑

第 7 章：全球血管炎治療市場，按疾病類型分類

  • 市場概況
  • 全球血管炎治療市場：按疾病類型進行性能潛力分析
  • 全球血管炎治療市場、按疾病類型估計和預測 (2019-2029)
  • 血管炎治療市場細分分析
    • 中小型血管炎
    • 大血管炎

第 8 章全球血管炎治療市場：按分銷渠道

  • 市場概況
  • 全球血管炎治療市場：按分銷渠道進行的性能潛力分析
  • 全球血管炎治療市場、按分銷渠道估算和預測 (2019-2029)
  • 血管炎治療市場細分分析
    • 醫院藥房
    • 藥店、零售藥店
    • 在線藥店

第 9 章全球血管炎治療市場：區域分析

  • 血管炎治療市場，按地區劃分的市場概況
  • 北美
    • 美國
      • 2019-2029 年按藥物類別的估計和預測
      • 按疾病類型估算和預測，2019-2029 年
      • 按銷售渠道估算和預測，2019 年至 2029 年
    • 加拿大
  • 歐洲血管炎治療市場概況
    • 英國
    • 德國
    • 法國
    • 西班牙
    • 意大利
    • 其他歐洲地區
  • 亞太地區血管炎治療市場概況
    • 中國
    • 印度
    • 日本
    • 澳大利亞
    • 韓國
    • 其他亞太地區
  • 拉丁美洲血管炎治療市場概況
    • 巴西
    • 墨西哥
    • 其他拉丁美洲地區
  • 世界其他地區

第 10 章衝突信息

  • 頂級市場策略
  • 公司簡介
    • Amneal Pharmaceuticals Inc.
      • 主要信息
      • 概覽
      • 財務信息（取決於數據可用性）
      • 產品概述
      • 近期趨勢
    • AstraZeneca plc
    • F. Hoffmann-La Roche Ltd
    • GlaxoSmithKline plc
    • Pfizer Inc.
    • InflaRx N.V
    • Novartis AG
    • ChemoCentryx Inc.
    • AbbVie Inc.
    • Teva Pharmaceutical Industries Ltd.

第 11 章研究過程

  • 研究過程
    • 數據挖掘
    • 分析
    • 市場評估
    • 驗證
    • 出版
  • 調查屬性
  • 調查先決條件

Global Vasculitis Treatment Market is valued at approximately USD 250.1 million in 2021 and is anticipated to grow with a healthy growth rate of more than 3.4% over the forecast period 2022-2029. Vasculitis Treatment is a rare inflammatory disease which affects blood vessels. The inflammation causes the walls of the blood vessels to thicken, which shortens the width of the passageway through the vessel and restricts blood flow. Moreover, restricted blood flow can result in organ failure and tissue damage. There are many types of vasculitis, such as Giant cell arteritis (GCA), Takayasu's arteritis (TAK), Aortitis, Kawasaki disease (KD), and Polyarteritis nodosa (PAN) among others. The general symptoms and signs of Vasculitis include Fever, Headache, Fatigue, Weight loss, General aches, pains, etc. The increasing vasculitis prevalence and growing incidences of chronic diseases as well as strategic initiatives from leading market players are key factors accelerating the market growth.

The increasing incidences of vasculitis prevalence are contributing towards the growth of the Global Vasculitis Treatment Market. For instance - according to Vasculitis UK - as of 2020, vasculitis affects 2000 to 3000 UK residents every year. Moreover, as per American Heart Association Journal - as of January 2021, in Sweden and Norway more than 20 new cases of GCA per 100 000 individuals aged 50 years and older are reported every year. Additionally, the lifetime risk of developing GCA is estimated at 1% for women and 0.5% for men in the United States. Also, the rapid growth of active pharmaceutical ingredient (API) industry and rising healthcare infrastructure in developing regions would create a lucrative growth prospectus for the market over the forecast period. However, side effects associated with corticosteroids and unfavorable reimbursement scenarios stifle market growth throughout the forecast period of 2022-2029.

The key regions considered for the Global Vasculitis Treatment Market study include Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America dominated the market in terms of revenue, owing to the presence of leading market players and increasing incidences of vasculitis in the region. Whereas Asia Pacific is expected to grow with the highest CAGR during the forecast period, owing to factors such as rising geriatric populations, and increasing expansion of pharmaceuticals manufacturing sector in the region.

Major market players included in this report are:

Amneal Pharmaceuticals Inc.

AstraZeneca plc

F. Hoffmann-La Roche Ltd

GlaxoSmithKline plc

Pfizer Inc.

InflaRx N.V

Novartis AG

ChemoCentryx Inc.

AbbVie Inc.

Teva Pharmaceutical Industries Ltd.

Recent Developments in the Market:

  • In September 2021, Vifor Fresenius Medical Care Renal Pharma (VFMCRP) announced that Japan's Ministry of Health and Labor Welfare (MHLW) has granted its partner, Kissei Pharmaceutical Co., Ltd., approval for marketing of TAVNEOS® for the treatment of patients with granulomatosis with polyangiitis (GPA) and microscopic polyangiitis (MPA).
  • In October 2022, Amgen completed its planned acquisition of ChemoCentryx, Inc. for a transaction value of USD 3.7 billion. This acquisition also includes TAVNEOS, an orally administered inhibitor that was approved by the U.S. Food and Drug Administration (FDA) in October 2021 for the treatment of severe active ANCA-associated vasculitis.

Global Vasculitis Treatment Market Report Scope:

Historical Data: 2019-2020-2021

Base Year for Estimation: 2021

Forecast period: 2022-2029

Report Coverage: Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends

Segments Covered: Drug Class, Disease Type, Distribution Channel, Region

Regional Scope: North America; Europe; Asia Pacific; Latin America; Rest of the World

Customization Scope: Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Drug Class

Biologics

Corticosteroids and immunosuppressants

By Disease Type

Small and medium vessel vasculitis

Large vessel vasculitis

By Distribution Channel

Hospital pharmacies

Drug stores and retail pharmacies

Online Pharmacies

By Region:

North America

U.S.

Canada

Europe

UK

Germany

France

Spain

Italy

ROE

Asia Pacific

China

India

Japan

Australia

South Korea

RoAPAC

Latin America

Brazil

Mexico

RoLA

Rest of the World

Table of Contents

Chapter 1. Executive Summary

  • 1.1. Market Snapshot
  • 1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Million)
    • 1.2.1. Vasculitis Treatment Market, by Region, 2019-2029 (USD Million)
    • 1.2.2. Vasculitis Treatment Market, by Drug Class, 2019-2029 (USD Million)
    • 1.2.3. Vasculitis Treatment Market, by Disease Type, 2019-2029 (USD Million)
    • 1.2.4. Vasculitis Treatment Market, by Distribution Channel, 2019-2029 (USD Million)
  • 1.3. Key Trends
  • 1.4. Estimation Methodology
  • 1.5. Research Assumption

Chapter 2. Global Vasculitis Treatment Market Definition and Scope

  • 2.1. Objective of the Study
  • 2.2. Market Definition & Scope
    • 2.2.1. Scope of the Study
    • 2.2.2. Industry Evolution
  • 2.3. Years Considered for the Study
  • 2.4. Currency Conversion Rates

Chapter 3. Global Vasculitis Treatment Market Dynamics

  • 3.1. Vasculitis Treatment Market Impact Analysis (2019-2029)
    • 3.1.1. Market Drivers
      • 3.1.1.1. Increasing vasculitis prevalence
      • 3.1.1.2. Growing incidences of chronic diseases
      • 3.1.1.3. Strategic initiatives from leading market players
    • 3.1.2. Market Challenges
      • 3.1.2.1. Side effects associated with corticosteroids
      • 3.1.2.2. Unfavourable reimbursement scenario
    • 3.1.3. Market Opportunities
      • 3.1.3.1. Growing active pharmaceutical ingredient (API) industry
      • 3.1.3.2. Rising healthcare infrastructure in developing regions

Chapter 4. Global Vasculitis Treatment Market Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
  • 4.2. Futuristic Approach to Porter's 5 Force Model (2019-2029)
  • 4.3. PEST Analysis
    • 4.3.1. Political
    • 4.3.2. Economical
    • 4.3.3. Social
    • 4.3.4. Technological
  • 4.4. Top investment opportunity
  • 4.5. Top winning strategies
  • 4.6. Industry Experts Prospective
  • 4.7. Analyst Recommendation & Conclusion

Chapter 5. Risk Assessment: COVID-19 Impact

  • 5.1. Assessment of the overall impact of COVID-19 on the industry
  • 5.2. Pre COVID-19 and post COVID-19 Market scenario

Chapter 6. Global Vasculitis Treatment Market, by Drug Class

  • 6.1. Market Snapshot
  • 6.2. Global Vasculitis Treatment Market by Drug Class, Performance - Potential Analysis
  • 6.3. Global Vasculitis Treatment Market Estimates & Forecasts by Drug Class 2019-2029 (USD Million)
  • 6.4. Vasculitis Treatment Market, Sub Segment Analysis
    • 6.4.1. Biologics
    • 6.4.2. Corticosteroid
    • 6.4.3. Immunosuppressants

Chapter 7. Global Vasculitis Treatment Market, by Disease Type

  • 7.1. Market Snapshot
  • 7.2. Global Vasculitis Treatment Market by Disease Type, Performance - Potential Analysis
  • 7.3. Global Vasculitis Treatment Market Estimates & Forecasts by Disease Type 2019-2029 (USD Million)
  • 7.4. Vasculitis Treatment Market, Sub Segment Analysis
    • 7.4.1. Small and medium vessel vasculitis
    • 7.4.2. Large vessel vasculitis

Chapter 8. Global Vasculitis Treatment Market, by Distribution Channel

  • 8.1. Market Snapshot
  • 8.2. Global Vasculitis Treatment Market by Distribution Channel, Performance - Potential Analysis
  • 8.3. Global Vasculitis Treatment Market Estimates & Forecasts by Distribution Channel 2019-2029 (USD Million)
  • 8.4. Vasculitis Treatment Market, Sub Segment Analysis
    • 8.4.1. Hospital pharmacies
    • 8.4.2. Drug store and retail pharmacies
    • 8.4.3. Online Pharmacies

Chapter 9. Global Vasculitis Treatment Market, Regional Analysis

  • 9.1. Vasculitis Treatment Market, Regional Market Snapshot
  • 9.2. North America Vasculitis Treatment Market
    • 9.2.1. U.S. Vasculitis Treatment Market
      • 9.2.1.1. Drug Class breakdown estimates & forecasts, 2019-2029
      • 9.2.1.2. Disease Type breakdown estimates & forecasts, 2019-2029
      • 9.2.1.3. Distribution Channel breakdown estimates & forecasts, 2019-2029
    • 9.2.2. Canada Vasculitis Treatment Market
  • 9.3. Europe Vasculitis Treatment Market Snapshot
    • 9.3.1. U.K. Vasculitis Treatment Market
    • 9.3.2. Germany Vasculitis Treatment Market
    • 9.3.3. France Vasculitis Treatment Market
    • 9.3.4. Spain Vasculitis Treatment Market
    • 9.3.5. Italy Vasculitis Treatment Market
    • 9.3.6. Rest of Europe Vasculitis Treatment Market
  • 9.4. Asia-Pacific Vasculitis Treatment Market Snapshot
    • 9.4.1. China Vasculitis Treatment Market
    • 9.4.2. India Vasculitis Treatment Market
    • 9.4.3. Japan Vasculitis Treatment Market
    • 9.4.4. Australia Vasculitis Treatment Market
    • 9.4.5. South Korea Vasculitis Treatment Market
    • 9.4.6. Rest of Asia Pacific Vasculitis Treatment Market
  • 9.5. Latin America Vasculitis Treatment Market Snapshot
    • 9.5.1. Brazil Vasculitis Treatment Market
    • 9.5.2. Mexico Vasculitis Treatment Market
    • 9.5.3. Rest of Latin America Vasculitis Treatment Market
  • 9.6. Rest of The World Vasculitis Treatment Market

Chapter 10. Competitive Intelligence

  • 10.1. Top Market Strategies
  • 10.2. Company Profiles
    • 10.2.1. Amneal Pharmaceuticals Inc.
      • 10.2.1.1. Key Information
      • 10.2.1.2. Overview
      • 10.2.1.3. Financial (Subject to Data Availability)
      • 10.2.1.4. Product Summary
      • 10.2.1.5. Recent Developments
    • 10.2.2. AstraZeneca plc
    • 10.2.3. F. Hoffmann-La Roche Ltd
    • 10.2.4. GlaxoSmithKline plc
    • 10.2.5. Pfizer Inc.
    • 10.2.6. InflaRx N.V
    • 10.2.7. Novartis AG
    • 10.2.8. ChemoCentryx Inc.
    • 10.2.9. AbbVie Inc.
    • 10.2.10. Teva Pharmaceutical Industries Ltd.

Chapter 11. Research Process

  • 11.1. Research Process
    • 11.1.1. Data Mining
    • 11.1.2. Analysis
    • 11.1.3. Market Estimation
    • 11.1.4. Validation
    • 11.1.5. Publishing
  • 11.2. Research Attributes
  • 11.3. Research Assumption

LIST OF TABLES

  • TABLE 1. Global Vasculitis Treatment Market, report scope
  • TABLE 2. Global Vasculitis Treatment Market estimates & forecasts by Region 2019-2029 (USD Million)
  • TABLE 3. Global Vasculitis Treatment Market estimates & forecasts by Drug Class 2019-2029 (USD Million)
  • TABLE 4. Global Vasculitis Treatment Market estimates & forecasts by Disease Type 2019-2029 (USD Million)
  • TABLE 5. Global Vasculitis Treatment Market estimates & forecasts by Distribution Channel 2019-2029 (USD Million)
  • TABLE 6. Global Vasculitis Treatment Market by segment, estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 7. Global Vasculitis Treatment Market by region, estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 8. Global Vasculitis Treatment Market by segment, estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 9. Global Vasculitis Treatment Market by region, estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 10. Global Vasculitis Treatment Market by segment, estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 11. Global Vasculitis Treatment Market by region, estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 12. Global Vasculitis Treatment Market by segment, estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 13. Global Vasculitis Treatment Market by region, estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 14. Global Vasculitis Treatment Market by segment, estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 15. Global Vasculitis Treatment Market by region, estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 16. U.S. Vasculitis Treatment Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 17. U.S. Vasculitis Treatment Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 18. U.S. Vasculitis Treatment Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 19. Canada Vasculitis Treatment Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 20. Canada Vasculitis Treatment Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 21. Canada Vasculitis Treatment Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 22. UK Vasculitis Treatment Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 23. UK Vasculitis Treatment Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 24. UK Vasculitis Treatment Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 25. Germany Vasculitis Treatment Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 26. Germany Vasculitis Treatment Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 27. Germany Vasculitis Treatment Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 28. France Vasculitis Treatment Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 29. France Vasculitis Treatment Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 30. France Vasculitis Treatment Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 31. Italy Vasculitis Treatment Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 32. Italy Vasculitis Treatment Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 33. Italy Vasculitis Treatment Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 34. Spain Vasculitis Treatment Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 35. Spain Vasculitis Treatment Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 36. Spain Vasculitis Treatment Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 37. RoE Vasculitis Treatment Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 38. RoE Vasculitis Treatment Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 39. RoE Vasculitis Treatment Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 40. China Vasculitis Treatment Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 41. China Vasculitis Treatment Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 42. China Vasculitis Treatment Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 43. India Vasculitis Treatment Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 44. India Vasculitis Treatment Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 45. India Vasculitis Treatment Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 46. Japan Vasculitis Treatment Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 47. Japan Vasculitis Treatment Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 48. Japan Vasculitis Treatment Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 49. South Korea Vasculitis Treatment Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 50. South Korea Vasculitis Treatment Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 51. South Korea Vasculitis Treatment Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 52. Australia Vasculitis Treatment Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 53. Australia Vasculitis Treatment Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 54. Australia Vasculitis Treatment Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 55. RoAPAC Vasculitis Treatment Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 56. RoAPAC Vasculitis Treatment Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 57. RoAPAC Vasculitis Treatment Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 58. Brazil Vasculitis Treatment Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 59. Brazil Vasculitis Treatment Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 60. Brazil Vasculitis Treatment Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 61. Mexico Vasculitis Treatment Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 62. Mexico Vasculitis Treatment Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 63. Mexico Vasculitis Treatment Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 64. RoLA Vasculitis Treatment Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 65. RoLA Vasculitis Treatment Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 66. RoLA Vasculitis Treatment Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 67. Row Vasculitis Treatment Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 68. Row Vasculitis Treatment Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 69. Row Vasculitis Treatment Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 70. List of secondary sources, used in the study of global Vasculitis Treatment Market
  • TABLE 71. List of primary sources, used in the study of global Vasculitis Treatment Market
  • TABLE 72. Years considered for the study
  • TABLE 73. Exchange rates considered

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

LIST OF FIGURES

List of figures

  • FIG 1. Global Vasculitis Treatment Market, research methodology
  • FIG 2. Global Vasculitis Treatment Market, Market estimation techniques
  • FIG 3. Global Market size estimates & forecast methods
  • FIG 4. Global Vasculitis Treatment Market, key trends 2021
  • FIG 5. Global Vasculitis Treatment Market, growth prospects 2022-2029
  • FIG 6. Global Vasculitis Treatment Market, porters 5 force model
  • FIG 7. Global Vasculitis Treatment Market, pest analysis
  • FIG 8. Global Vasculitis Treatment Market, value chain analysis
  • FIG 9. Global Vasculitis Treatment Market by segment, 2019 & 2029 (USD Million)
  • FIG 10. Global Vasculitis Treatment Market by segment, 2019 & 2029 (USD Million)
  • FIG 11. Global Vasculitis Treatment Market by segment, 2019 & 2029 (USD Million)
  • FIG 12. Global Vasculitis Treatment Market by segment, 2019 & 2029 (USD Million)
  • FIG 13. Global Vasculitis Treatment Market by segment, 2019 & 2029 (USD Million)
  • FIG 14. Global Vasculitis Treatment Market, regional snapshot 2019 & 2029
  • FIG 15. North America Vasculitis Treatment Market 2019 & 2029 (USD Million)
  • FIG 16. Europe Vasculitis Treatment Market 2019 & 2029 (USD Million)
  • FIG 17. Asia Pacific Vasculitis Treatment Market 2019 & 2029 (USD Million)
  • FIG 18. Latin America Vasculitis Treatment Market 2019 & 2029 (USD Million)
  • FIG 19. Global Vasculitis Treatment Market, company Market share analysis (2021)

List of tables and figures and dummy in nature, final lists may vary in the final deliverable